AIP
KZR

Ameritas Investment Partners’s Kezar Life Sciences KZR Stock Holding History

Ameritas Investment Partners’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-413
Closed -$3.72K – 3187
2024
Q1 		$3.72K Hold
413
– – ﹤0.01% 2984
2023
Q4 		$3.91K Hold
413
– – ﹤0.01% 3009
2023
Q3 		$4.91K Hold
413
– – ﹤0.01% 2988
2023
Q2 		$10.1K Hold
413
– – ﹤0.01% 2909
2023
Q1 		$12.9K Hold
413
– – ﹤0.01% 2628
2022
Q4 		$28.1K Hold
413
– – ﹤0.01% 2403
2022
Q3 		$35K Buy
413
+119
+40% +$11.6K ﹤0.01% 2221
2022
Q2 		$24K Hold
294
– – ﹤0.01% 2461
2022
Q1 		$49K Buy
294
+70
+31% +$10K ﹤0.01% 2068
2021
Q4 		$37K Hold
224
– – ﹤0.01% 2321
2021
Q3 		$19K Hold
224
– – ﹤0.01% 2730
2021
Q2 		$12K Hold
224
– – ﹤0.01% 2903
2021
Q1 		$13K Hold
224
– – ﹤0.01% 2746
2020
Q4 		$12K Hold
224
– – ﹤0.01% 2710
2020
Q3 		$11K Hold
224
– – ﹤0.01% 2667
2020
Q2 		$12K Hold
224
– – ﹤0.01% 2630
2020
Q1 		$10K Buy
224
+120
+115% +$4.88K ﹤0.01% 2551
2019
Q4 		$4K Hold
104
– – ﹤0.01% 2921
2019
Q3 		$3K Hold
104
– – ﹤0.01% 2983
2019
Q2 		$8K Hold
104
– – ﹤0.01% 2864
2019
Q1 		$18K Buy
104
+63
+154% +$12.4K ﹤0.01% 2432
2018
Q4 		$10K Hold
41
– – ﹤0.01% 2662
2018
Q3 		$9K Buy
+41
New +$7.16K ﹤0.01% 2863

Other funds holding KZR

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Ameritas Investment Partners's KZR Position: Q2 2024 in Review

Ameritas Investment Partners sold out of Kezar Life Sciences (KZR) in Q2 2024, closing a stake of 413 shares — an estimated $3.72K sold.

Ameritas Investment Partners first reported a position in KZR in Q3 2018 and held it in 23 quarters. The position peaked at $49K in Q1 2022. 81 funds tracked by Wall St. Rank hold KZR as of Q2 2024.

  • Ameritas Investment Partners reported no remaining Kezar Life Sciences position as of Q2 2024 after selling out during the quarter.
  • Ameritas Investment Partners sold 413 Kezar Life Sciences shares in Q2 2024, an estimated $3.72K.
  • Ameritas Investment Partners first reported a position in Kezar Life Sciences in Q3 2018 and held it in 23 quarters.
  • Ameritas Investment Partners's Kezar Life Sciences position peaked at $49K in Q1 2022.
  • 81 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q2 2024.

Based on Ameritas Investment Partners's 13F filing for Q2 2024, filed 13 Aug 2024.